Display Settings:


Send to:

Choose Destination
See comment in PubMed Commons below
Can J Gastroenterol. 2004 May;18(5):321-6.

Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory to standard therapy.

Author information

  • 1Liver Unit, Division of Gastroenterology, University of Calgary Medical Clinic, 330 Hospital Drive Northwest, Calgary, Alberta, Canada T2N 4N1.


There are limited therapeutic options available for patients with autoimmune hepatitis in whom conventional treatment fails. A case series of five patients unresponsive to or unable to take azathioprine, 6-mercaptopurine or corticosteroids who were treated with mycophenolate mofetil (MMF) is reported. While on MMF, alanine aminotransferase normalized or remained normal in all patients. MMF had a steroid-sparing effect and histological remission was demonstrated in one patient after seven months of MMF. One patient experienced an uncomplicated episode of pyelonephritis. In conclusion, MMF can effectively induce and maintain remission in refractory autoimmune hepatitis patients.

Comment in

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Pulsus Group Inc
    Loading ...
    Write to the Help Desk